JPH04151541A - Cell analyzing apparatus - Google Patents

Cell analyzing apparatus

Info

Publication number
JPH04151541A
JPH04151541A JP27335290A JP27335290A JPH04151541A JP H04151541 A JPH04151541 A JP H04151541A JP 27335290 A JP27335290 A JP 27335290A JP 27335290 A JP27335290 A JP 27335290A JP H04151541 A JPH04151541 A JP H04151541A
Authority
JP
Japan
Prior art keywords
blood
measurement
measuring
cell
lymphocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP27335290A
Other languages
Japanese (ja)
Inventor
Hideyuki Horiuchi
堀内 秀之
Shinichi Sakuraba
桜庭 伸一
Nobuyuki Tatara
多田羅 信之
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hitachi Instruments Engineering Co Ltd
Hitachi Ltd
Original Assignee
Hitachi Instruments Engineering Co Ltd
Hitachi Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi Instruments Engineering Co Ltd, Hitachi Ltd filed Critical Hitachi Instruments Engineering Co Ltd
Priority to JP27335290A priority Critical patent/JPH04151541A/en
Publication of JPH04151541A publication Critical patent/JPH04151541A/en
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

PURPOSE:To improve the measuring accuracy for few blood corpuscles by performing the counting of the blood corpuscles beforehand, measuring the number of erythrocytes, the number of leukocytes and the number of lymphocytes, and determining the measuring conditions in analysis based on the measured results. CONSTITUTION:In a blood-cell data analyzing part 3, the measuring conditions for the next measurement are analyzed based on the counted data of blood cells. In a measuring-condition setting part 5, the measuring conditions of a measuring system are set based on the result of the analysis. Before the analysis of the cells in the blood, the number of erythrocytes, the number of leukocytes and the number of lymphocytes in the leukocytes are measured beforehand in a blood-corpuscle counting part 2. In the setting part 5, at first, the counted data of the blood corpuscles are analyzed, and the number of the erythroxytes, the number of leukocytes and the number of the lymphocytes in a unit volume are detected and compared with the number of the erythrocytes, the number of leukocytes and the number of the lymphocytes for ensuring the sufficient accuracy. Thus, the amount of the blood sample to be treated is determined. The conditions such as the elongation of the measuring time, the increase in sucking amount of the diluted blood to be measured, the increase in amount of determination and sending of the blood and the increase in flowing speed are determined. Thus, the measuring accuracy for the few blood corpuscles can be improved.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は1個1個の血液細胞にレーザ光を照射して、細
胞からの散乱光や蛍光強度から血液細胞の種類や機能の
違いを測定するいわゆるフローサイトメータに関する。
[Detailed Description of the Invention] [Industrial Application Field] The present invention irradiates individual blood cells with laser light and detects differences in blood cell types and functions from the scattered light and fluorescence intensity from the cells. It relates to a so-called flow cytometer for measuring.

〔従来の技術〕[Conventional technology]

従来フローサイトメータはシースフローといって、血液
を生理食塩水などで希釈した細胞標本を外側の流れによ
って包み込む形で、測定フローセル中を流す。これは細
胞1個1個に強力なレーザ光を照射し測定に十分な蛍光
強度を得るためである。フローサイトメータには広範な
測定対象があり、当初基礎研究に使われていたが、近年
白血球中のリンパ球のサブセント(亜種・・Tセル・B
セルなど)の検査や白血球自身の分類、網赤血球計数な
どへの応用において病院内臨床検査室で広く使われ始め
ている。
Conventional flow cytometers use a sheath flow system, in which a cell specimen prepared by diluting blood with physiological saline is surrounded by an external flow through a measurement flow cell. This is to irradiate each cell with a strong laser beam to obtain sufficient fluorescence intensity for measurement. Flow cytometers have a wide range of measurement targets, and were initially used for basic research, but in recent years, they have been used to measure subcentres of lymphocytes (subspecies, T cells, B cells, etc.) in white blood cells.
It has begun to be widely used in clinical laboratories in hospitals for applications such as testing of cells (e.g., white blood cells), classification of white blood cells themselves, and counting of reticulocytes.

蛍光標識されたモノクローナル抗体がリンパ球細胞表面
に結合するかしないかによって、その抗体に対する陽性
または陰性を蛍光強度で測定する。
Depending on whether the fluorescently labeled monoclonal antibody binds to the surface of lymphocytes, positivity or negativity for the antibody is determined by fluorescence intensity.

この測定に必要な前処理は、従来長時間の作業と熟練を
必要としたが、最近ではアナリテイカルクリニカル ラ
ボラトリ−、P 32 (Oct、1988)(ACL
  P 32.  (Oct、1988) )に述べら
れているごとく試薬の改良と前処理技術の発達により、
非常に簡単になってきている。
The preprocessing required for this measurement conventionally required long hours of work and skill, but recently it has been proposed by Analytical Clinical Laboratory, P 32 (Oct. 1988) (ACL
P 32. (Oct, 1988)), with the improvement of reagents and the development of pretreatment technology,
It's getting very easy.

〔発明が解決しようとする課題〕[Problem to be solved by the invention]

しかしこの検査において、血液標本によってはリンパ球
の数が非常に少なかったり赤血球の溶血が十分でないた
め、正確な陽性率を測定できなかったり、赤血球破片に
よる光散乱によるゴースト信号が測定に影響することが
ある。−律な測定条件のもとでは、上記のような血液標
゛本は十分対応できない場合がある。
However, in this test, depending on the blood sample, the number of lymphocytes may be very low or the red blood cells may not be sufficiently hemolyzed, so it may not be possible to accurately measure the positive rate, or ghost signals caused by light scattering from red blood cell fragments may affect the measurement. There is. - Under standard measurement conditions, blood specimens such as those described above may not be sufficient.

第2図(a)(b)を使って説明する。第2図は蛍光標
識されたモノクローナル抗体をリンパ球に作用させ、そ
の抗体のリンパ球との結合度合いを調へ、陽性、陰性の
割合からリンパ球のサブセット(亜種)の存在を測定す
る。第2図(a)に示したように、測定にはまずレーザ
光による側方散乱強度と前方散乱強度の2つのパラメー
タで白血球をリンパ球、単球2粒球の3つに分類する。
This will be explained using FIGS. 2(a) and (b). In Figure 2, a fluorescently labeled monoclonal antibody is applied to lymphocytes, the degree of binding of the antibody to lymphocytes is measured, and the presence of subsets (subspecies) of lymphocytes is determined from the ratio of positive and negative responses. As shown in FIG. 2(a), in the measurement, white blood cells are first classified into three types: lymphocytes, monocytes, and two granulocytes using two parameters, side scattering intensity and forward scattering intensity, by laser light.

必要なリンパ球を選び出し、リンパ球だけがら第2図(
b)に示した蛍光強度のヒストグラム分布を作り、総リ
ンパ球数に対する陽性細胞数の割合を計算する。
Select the necessary lymphocytes and extract only the lymphocytes as shown in Figure 2 (
Create a histogram distribution of the fluorescence intensity shown in b) and calculate the ratio of the number of positive cells to the total number of lymphocytes.

もとのリンパ球数が十分あれば問題はないが、数が少な
いと(b)に示した点線ようにヒストグラムの高さが低
く、陽性、陰性の区別が出来なかったり、数不足のため
統計的誤差も大きく、そのため測定精度が悪くなる。
There is no problem if the original number of lymphocytes is sufficient, but if the number is low, the height of the histogram will be low as shown by the dotted line in (b), and it may be impossible to distinguish between positive and negative lymphocytes, or the statistics may be difficult due to insufficient numbers. The error is also large, which reduces measurement accuracy.

また、(a)の点線で示した溶血不良による赤血球破片
が現れると領域的にリンパ球と重なり、その結果、正確
なリンパ球数を測定できなかったり、陰性率の増加の原
因になる。反対に溶血が進行しすぎ白血球自身が破壊さ
れてしまうこともある。
Further, when red blood cell fragments due to poor hemolysis shown by the dotted line in (a) appear, they overlap with lymphocytes in a region, which results in an inability to accurately measure the number of lymphocytes and an increase in the negative rate. On the other hand, hemolysis may progress too much and the white blood cells themselves may be destroyed.

このような問題は、白血球分類や網赤血球計数などフロ
ーサイトメータ方式の類似の検査項目にても発生する。
Such problems also occur in similar test items performed using a flow cytometer, such as white blood cell classification and reticulocyte counting.

白血球分類ではもとになる白血球数の多い少ないは、分
類の測定精度に直接影響するパラメータである。特に数
が少ない時には各種白血球ごとの十分なまとまりのある
データが得られないこともあり、統計的な誤差とともに
各血球分類識別アルゴリズムが正常に働かない場合があ
る。また、特定の白血球だけが溶血され易いこともある
In white blood cell classification, whether the number of white blood cells is high or low is a parameter that directly affects the measurement accuracy of the classification. Particularly when the number of white blood cells is small, it may not be possible to obtain sufficiently comprehensive data for each type of white blood cell, and due to statistical errors, each blood cell classification algorithm may not function properly. Furthermore, only certain white blood cells may be susceptible to hemolysis.

上述したような一律の測定条件では対応できない血液標
本では再測定を行う必要があるが、そのためにはもう1
度採血、前処理等の過程がいるし、また測定装置の測定
条件を別に設定しなければならない。大量の血液標本を
取り扱う施設では煩雑で時間がかかる作業となる。
Blood specimens that cannot be measured under the uniform measurement conditions described above must be remeasured, but in order to do so, one more step is required.
It requires multiple blood sampling and pretreatment processes, and measurement conditions for the measuring device must be set separately. In facilities that handle a large number of blood specimens, this is a complicated and time-consuming process.

本発明の目的は、−律な測定条件では対応できない血液
標本に対し、自動的に測定条件を変更し設定する事によ
り対応するようにした血液細胞分析装置を提供すること
にある。
SUMMARY OF THE INVENTION An object of the present invention is to provide a blood cell analyzer that can automatically change and set measurement conditions to handle blood samples that cannot be handled under standard measurement conditions.

〔課題を解決するための手段〕[Means to solve the problem]

上記目的を達成するために、血液細胞分析装置で測定す
る前に、血球計数を行い赤血球数、白血球数、さらに白
血球の中のリンパ球数をあらかじめ測定し、その測定結
果を基にして血液細胞分析の測定条件を決定するように
する。また、前処理行程で行う赤血球溶血において、血
液の溶血状態を光透過率で観測し光透過率の値または変
化状態の測定から知る。血液が十分溶血されたら、溶血
行程を終了して、次の細胞分析を開始する。
In order to achieve the above purpose, before measuring with a blood cell analyzer, we perform a blood cell count to measure the number of red blood cells, white blood cells, and lymphocytes among white blood cells, and based on the measurement results, we measure blood cells. Be sure to determine the measurement conditions for analysis. In addition, during red blood cell hemolysis carried out in the pretreatment process, the hemolyzed state of blood is observed by light transmittance, and can be known from the measurement of the value or state of change in light transmittance. Once the blood has been sufficiently hemolyzed, the hemolysis step is completed and the next cell analysis begins.

細胞分析に必要な条件としては次のものが考えられる。The following conditions may be considered necessary for cell analysis.

十分な精度を保証する白血球数またはリンパ球数を確保
することである。赤血球の溶血状態製監視し、溶血不足
や溶血過多を起こさないようにする。網赤血球計数では
十分な赤血球数を確保する必要がある。さらに血小板凝
集があると第2図(a)の赤血球破片位置に現れるがこ
れもデータ処理で取り除かなければならない。
The goal is to ensure a white blood cell or lymphocyte count that guarantees sufficient accuracy. Monitor the hemolyzed state of red blood cells to prevent insufficient or excessive hemolysis. For reticulocyte counting, it is necessary to ensure a sufficient number of red blood cells. Furthermore, if there is platelet aggregation, it will appear at the position of red blood cell debris as shown in FIG. 2(a), but this must also be removed by data processing.

以上のような測定条件を確保するために血球計数で測定
される情報、及び溶血状態を監視する光透適才測定部を
使する。
In order to ensure the above measurement conditions, information measured by a blood cell count and a light transmittance measurement unit that monitors the state of hemolysis are used.

通常の血球計数では、コールタ原理による電気抵抗測定
により、血球数及び血球体積や血球体積ヒストグラム情
報が得られる。赤血球数及び白血球数の不足は、単位体
積あたりの血球数から解る。
In normal blood cell counting, blood cell count, blood cell volume, and blood cell volume histogram information are obtained by measuring electrical resistance based on the Coulter principle. Deficiencies in the number of red blood cells and white blood cells can be determined from the number of blood cells per unit volume.

リンパ球数は、白血球体積ヒストグラムから知ることが
出来る。体積ヒストグラムの1例を第3図に示す。血小
板凝集の有無は赤血球体積ヒストグラムの赤血球と血小
板の中間にその存在を示す。
The number of lymphocytes can be determined from the white blood cell volume histogram. An example of a volume histogram is shown in FIG. The presence or absence of platelet aggregation indicates its presence between red blood cells and platelets in the red blood cell volume histogram.

赤血球溶血状態は、光透過率測定で知る。希釈した血液
に溶血剤を添加すると、第4図に示したように時間経過
とともに光透過率が変化する。始め低透過率であるが、
ある時間to経過後急速に透過率が上昇する。その後光
透過率は飽和傾向を示す。この飽和傾向の適当な時点で
溶血操作を終了し、細胞分析測定に血液標本を送り測定
を開始する。
The state of red blood cell hemolysis can be determined by measuring light transmittance. When a hemolytic agent is added to diluted blood, the light transmittance changes over time as shown in FIG. Initially, the transmittance is low, but
After a certain period of time has elapsed, the transmittance increases rapidly. After that, the light transmittance shows a tendency to saturate. The hemolytic operation is terminated at an appropriate point in time when the saturation tendency is reached, and the blood sample is sent for cell analysis and measurement is started.

細胞分析のための条件設定は次のように行う。Conditions for cell analysis are set as follows.

まず、血球計数データの解析を行い、単位体積当たりの
赤血球数、白血球数、リンパ球数を決定し、測定精度と
して必要な赤血球数、白血球数、リンパ球数と比較して
処理血液サンプル量を決める。
First, analyze the blood cell count data, determine the number of red blood cells, white blood cells, and lymphocytes per unit volume, and compare the numbers of red blood cells, white blood cells, and lymphocytes required for measurement accuracy to determine the amount of blood sample to be processed. decide.

全ての血液標本に対して測定条件を定めるのではなくて
、極端に数の少ない標本に限り、通常の測定条件を変更
し正常者の場合と同じ程度の処理血球数にするのが基本
である。測定条件には、測定時間の延長、測定希釈血液
吸引量を増やす、測定系への血液定量送り量の増大や流
速の増加、シース液量の制御などの項目が考えられる。
Rather than setting measurement conditions for all blood specimens, it is basic to change the normal measurement conditions only for extremely small number of specimens and process blood cells to the same number as in normal subjects. . Possible measurement conditions include extending the measurement time, increasing the measured diluted blood suction volume, increasing the fixed amount of blood sent to the measurement system, increasing the flow rate, and controlling the sheath fluid volume.

測定時間を変えない条件ならば、測定系への血液定量送
り量を増やす事になるが、シース液流量を変えないなら
ばこれはフローセル中の血液サンプルの流れの直径を大
きくする事になる。この場合光学系、特に集束レーザビ
ームのサイズからサンプル直径の上限がある。反対にシ
ース液流量も増やす場合には、サンプルの直径は変化し
ないが、フロー系の制御パラメータが多くなる。
If the measurement time is not changed, the fixed amount of blood sent to the measurement system will be increased, but if the sheath fluid flow rate is not changed, this will increase the diameter of the flow of the blood sample in the flow cell. In this case, there is an upper limit to the sample diameter due to the size of the optical system, especially the focused laser beam. On the other hand, when the sheath liquid flow rate is also increased, the sample diameter does not change, but the flow system control parameters increase.

血小板凝集のある血液標本に対しては、細胞データ処理
に対し血小板凝集のある標本である事を知らせ、処理の
中で血小板データを消去する。
For blood samples with platelet aggregation, the cell data processing is informed that the sample has platelet aggregation, and the platelet data is deleted during the processing.

〔作用〕[Effect]

赤血球計数する手段を有し、血液細胞分析装置で測定す
る前に、血球計数を行い赤血球数、白血球数、さらに白
血球の中のリンパ球数をあらかしめ測定し、血液細胞分
析の測定条件設定部においてその測定結果を基に測定精
度として必要な赤血球数、白血球数、リンパ球数と比較
して処理血液サンプル量を決める手段、及び測定系を制
御する手段により、血液細胞分析精度の向上を計る事を
特徴とする。
It has a means for counting red blood cells, performs blood cell counting, and preliminarily measures the number of red blood cells, white blood cells, and lymphocytes among white blood cells before measurement with a blood cell analyzer, and includes a measurement condition setting section for blood cell analysis. The accuracy of blood cell analysis is improved by means of determining the amount of blood sample to be processed by comparing the measurement results with the number of red blood cells, white blood cells, and lymphocytes required for measurement accuracy, and by means of controlling the measurement system. characterized by things.

また、細胞分析装置における前処理行程で行う赤血球溶
血操作において、血液の溶血状態を光透過率で観測し光
透過率の値または変化状態の測定から知ることにより、
細胞分析における赤血球破片による誤測定を低減するこ
とを特徴とする。
In addition, in the red blood cell hemolysis operation performed in the pretreatment process of a cell analyzer, by observing the hemolyzed state of blood using light transmittance and determining the value or change state of the light transmittance,
It is characterized by reducing measurement errors caused by red blood cell debris in cell analysis.

このように1つ前の血球測定データにより次の血液細胞
分析測定の測定条件を判断、決定し、測定ハードを制御
し、かつ血球前処理における赤血球溶血条件を光透過率
測定から判断することにより、従来問題になっていた白
血球個数またはリンパ球個数の少ない血液標本や、個体
差のある血液溶血剤の作用の影響を少なくし、結果とし
て血液分析装置の測定精度を向上する事が出来る。
In this way, the measurement conditions for the next blood cell analysis measurement are judged and determined based on the previous blood cell measurement data, the measurement hardware is controlled, and the red blood cell hemolysis conditions in blood cell pretreatment are determined from the light transmittance measurement. It is possible to reduce the effects of blood specimens with a low number of white blood cells or lymphocytes, which have been a problem in the past, and the effects of blood hemolytic agents, which vary between individuals, and as a result, the measurement accuracy of the blood analyzer can be improved.

〔実施例〕〔Example〕

以下、本発明について実施例にて説明する。 The present invention will be explained below with reference to Examples.

(実施例1) 本発明の一実施例を第1図にで説明する。(Example 1) An embodiment of the present invention will be explained with reference to FIG.

図において、1は血液標本、2は血球カウンタ(計数)
部、3が血算データ分析部、4は血液前処理部である。
In the figure, 1 is a blood sample, 2 is a blood cell counter (counting)
3 is a blood count data analysis section, and 4 is a blood preprocessing section.

5は血液前処理部4および細胞分析部6の測定条件を設
定する測定条件設定部である。細胞分析部6での測定デ
ータは7の細胞データ分析部でデータ処理され、制御部
8から外部に測定結果が出力される。制御部8は測定装
置全体の制御を行う。
Reference numeral 5 denotes a measurement condition setting section for setting measurement conditions for the blood pretreatment section 4 and the cell analysis section 6. The measurement data from the cell analysis section 6 is processed by the cell data analysis section 7, and the measurement results are output from the control section 8 to the outside. The control unit 8 controls the entire measuring device.

血球計数部2ては、赤血球数、白血球数、リンパ球数な
どを測定する。血算データ分析部3では、血球計数部2
のデータからリンパ球数については第3図に示した白血
球体積ヒストグラムのリンパ球部分の割合から決定する
。血小板凝集は赤血球体積ヒストグラムの血小板分布と
赤血球分布の中間領域に凝集した血小板が存在するかど
うかで決定する。血算データ分析部3の結果は測定条件
設定部5に伝え、細胞分析部6および血液前処理部4の
処理条件を決める。
The blood cell counting section 2 measures the number of red blood cells, white blood cells, lymphocytes, etc. In the blood count data analysis section 3, the blood cell counting section 2
From the data, the number of lymphocytes is determined from the percentage of lymphocytes in the white blood cell volume histogram shown in FIG. Platelet aggregation is determined by whether aggregated platelets are present in the intermediate region between the platelet distribution and the red blood cell distribution in the red blood cell volume histogram. The results of the blood count data analysis section 3 are transmitted to the measurement condition setting section 5, which determines the processing conditions for the cell analysis section 6 and blood pretreatment section 4.

処理条件としては次のものがある。The processing conditions include the following.

小数血球の処理に対しては、測定血球数を増加させる。For treatment of minority blood cells, the measured blood cell count is increased.

すなわち測定血液希釈サンプルの測定吸引量を増やす。That is, increase the measured aspiration amount of the measured hemodilution sample.

測定時間を長くする場合には、測定用フローセルに流す
血液サンプル及びシース液の単位時間当たりの流量は変
えなくて良い。しかし、測定時間が変更できない場合に
は、血液サンプルだけ流量を増加させるか、シース液流
量も増加させる2通りの選択がある。前者では、測定フ
ローセル中の血液サンプル流の直径が増し、レーザビー
ムを始め光学系の設定に制限がある。後者ではシース液
の流れも制御する必要がある。
When increasing the measurement time, the flow rates per unit time of the blood sample and sheath fluid flowing through the measurement flow cell do not need to be changed. However, if the measurement time cannot be changed, there are two options: increasing the flow rate only for the blood sample, or increasing the sheath fluid flow rate as well. In the former case, the diameter of the blood sample flow in the measurement flow cell increases, and there are limitations on the settings of the optical system, including the laser beam. In the latter case, it is also necessary to control the flow of sheath fluid.

無制限に測定血液希釈サンプルの量を増加させることは
出来ないため、適当な上限を定める必要がある。この判
断も測定条件設定部5の仕事である。
Since it is not possible to increase the amount of hemodilution sample to be measured without limit, it is necessary to set an appropriate upper limit. This judgment is also the job of the measurement condition setting section 5.

連続的な測定条件の設定は現実的でないから、正常範囲
に入る血液標本では一律な条件設定、それ以外の範囲で
もディスクリートな条件設定で十分である。
Since it is not practical to set continuous measurement conditions, it is sufficient to set uniform conditions for blood samples that fall within the normal range, and to set discrete conditions for other ranges.

白血球が少ない場合には、血液前処理部4での希釈倍率
を小さくすることも条件設定として可能である。元々数
が少ないから血球同士の同時通過は少ない。ただし、希
釈倍率の違いによる前処理条件の変化について知ってお
く必要がある。
When the number of white blood cells is small, it is also possible to set conditions by reducing the dilution ratio in the blood preprocessing section 4. Since the number of blood cells is originally small, it is rare for blood cells to pass through each other at the same time. However, it is necessary to be aware of changes in pretreatment conditions due to differences in dilution ratio.

希釈条件を変えるには、血液吸引量及び希釈液吸引量を
制御する。
To change the dilution conditions, the amount of blood aspirated and the amount of diluted liquid aspirated are controlled.

全体の処理の過程を示すタイムチャートを第5図に示す
A time chart showing the entire process is shown in FIG.

(実施例2) 赤血球溶血剤は種類によって溶血の効果まちまちであり
、血液標本の違い、保存状態、取扱いや前処理条件によ
って異なる。そのため第2図に示した未溶血赤血球や赤
血球破片がリンパ球と誤判定される結果になる。
(Example 2) The hemolyzing effect of red blood cell hemolysing agents varies depending on the type, and varies depending on the blood specimen, storage conditions, handling, and pretreatment conditions. As a result, the unlysed red blood cells and red blood cell fragments shown in FIG. 2 are mistakenly determined to be lymphocytes.

本発明では、この未溶血赤血球の状態を光透過率測定で
監視する。光透過率がある一定値以上になったときか、
または透過率の大きな変化をしたあと平坦領域に入って
あらかしめ決められた時間経過後に溶血操作を停止し、
細胞分析測定をスタートさせる。このようにして赤血球
の溶血条件を揃える事が出来、誤差の少ない細胞分析が
行える。
In the present invention, the state of these unhemolyzed red blood cells is monitored by measuring light transmittance. When the light transmittance exceeds a certain value,
Or, after entering a flat region after a large change in transmittance, the hemolytic operation is stopped after a predetermined period of time has elapsed.
Start cell analysis measurement. In this way, the conditions for hemolysis of red blood cells can be aligned, and cell analysis can be performed with less error.

赤血球サンプルの光透過率測定は、光源として光ランプ
、半導体レーザ、LED等を使用する。
The light transmittance measurement of a red blood cell sample uses a light lamp, semiconductor laser, LED, etc. as a light source.

血液前処理を行うガラス反応容器の前後に光源と光検出
器をセットし、透過光量の大小を測定し光透過率を求め
る。透過光量の時間変化を溶血開始から測定する。
A light source and a photodetector are set before and after the glass reaction container where blood pretreatment is performed, and the amount of transmitted light is measured to determine the light transmittance. The time change in the amount of transmitted light is measured from the start of hemolysis.

〔発明の効果〕〔Effect of the invention〕

本発明によれば以下に述べるような効果がある。 According to the present invention, there are effects as described below.

(1)従来問題になっていた数の少ない血球における細
胞分析の測定精度を、あらかじめ別な測定手段で対象血
球数を調べること、及びその結果に基づき細胞分析の処
理血球数を増加させるように測定条件を設定するため、
細胞分析の測定精度を向上させることが出来る。
(1) The measurement accuracy of cell analysis using a small number of blood cells, which has been a problem in the past, has been improved by checking the number of target blood cells in advance using a different measurement method, and increasing the number of blood cells processed for cell analysis based on the results. To set measurement conditions,
The measurement accuracy of cell analysis can be improved.

(2)光透過率の変化を逐次測定しながら赤血球の溶血
状態を測定する手段を有し、十分溶血した状態で細胞分
析できるため、血液前処理における赤血球溶血不足によ
る細胞分析における誤測定を少なくすることが出来、結
果として細胞分析精度の向上が計れる。
(2) It has a means to measure the hemolyzed state of red blood cells while sequentially measuring changes in light transmittance, and since cells can be analyzed in a sufficiently hemolyzed state, there are fewer erroneous measurements in cell analysis due to insufficient red blood cell hemolysis during blood pretreatment. As a result, the accuracy of cell analysis can be improved.

(3) (1)及び(2)により測定条件を血液標本ご
とに自動的に変更して設定してくれるため、再測定、前
処理のやり直しが無くなり、操作性の向上と測定時間の
短縮化が計れる。
(3) (1) and (2) automatically change and set the measurement conditions for each blood sample, eliminating the need for re-measurement or pre-processing, improving operability and shortening measurement time. can be measured.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明の構成を示すブロックダイアグラムを示
す図、第2図(a)(b)はリンパ球サブセット処理の
測定方法を示すもので、(a)は光散乱情報によるリン
パ球を取り出すパラメータ分布図、(b)は蛍光標識さ
れたモノクローナル抗体がリンパ球に結合したときの蛍
光強度のヒストグラムを示す図、第3図は白血球体積の
ヒストグラムの1例を示す図、第4図は血液希釈標本に
溶血剤を作用させたときの光透過率の時間変化を示す図
、第5図は第1図における各処理のタイムチャートであ
る。 1・・血液標本、2・・・血球カウンタ部、3・・・血
算デ−タ分析部、 4・・・血液前処理部、 5・・・測定条件説 走部、 6・・・細胞分析部、 7・・・細胞データ分析部、 第 図 第2図 m珠伴権 時間
Figure 1 shows a block diagram showing the configuration of the present invention, and Figures 2 (a) and (b) show a method for measuring lymphocyte subset processing, where (a) shows lymphocytes being extracted using light scattering information. Parameter distribution diagram, (b) is a diagram showing a histogram of fluorescence intensity when a fluorescently labeled monoclonal antibody binds to lymphocytes, Figure 3 is a diagram showing an example of a histogram of white blood cell volume, and Figure 4 is a diagram showing blood FIG. 5 is a diagram showing the change in light transmittance over time when a hemolytic agent is applied to a diluted sample, and is a time chart of each process in FIG. 1. 1. Blood specimen, 2. Blood cell counter section, 3. Blood count data analysis section, 4. Blood preprocessing section, 5. Measurement condition analysis section, 6. Cells. Analysis Department, 7...Cell Data Analysis Department, Figure 2

Claims (1)

【特許請求の範囲】 1、血球計数データをもとに、次に行う測定に関する測
定条件を分析する血算データ分析部と、その分析結果を
もとに測定系の測定条件を設定する測定条件設定部、及
びその測定条件でもつて細胞分析部を制御する制御部か
らなり、測定条件を個々の血液標本ごとに設定すること
を特徴とする細胞分析装置。 2、赤血球の溶血状態を光透過率にて測定する手段、そ
の測定結果のデータ系列から溶血度合いを識別する手段
からなる血液前処理部を有し、溶血が完了した時点から
細胞分析を開始し、赤血球未溶血による分析誤差を小さ
くすることを特徴とする細胞分析装置。
[Claims] 1. A blood count data analysis unit that analyzes measurement conditions for the next measurement based on blood cell count data, and measurement conditions that sets measurement conditions for the measurement system based on the analysis results. 1. A cell analysis device comprising a setting section and a control section for controlling a cell analysis section with measurement conditions thereof, and setting measurement conditions for each blood sample. 2. It has a blood preprocessing section consisting of a means for measuring the hemolyzed state of red blood cells by light transmittance and a means for identifying the degree of hemolysis from the data series of the measurement results, and starts cell analysis from the time hemolysis is completed. , a cell analysis device characterized by reducing analysis errors due to unhemolyzed red blood cells.
JP27335290A 1990-10-15 1990-10-15 Cell analyzing apparatus Pending JPH04151541A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27335290A JPH04151541A (en) 1990-10-15 1990-10-15 Cell analyzing apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27335290A JPH04151541A (en) 1990-10-15 1990-10-15 Cell analyzing apparatus

Publications (1)

Publication Number Publication Date
JPH04151541A true JPH04151541A (en) 1992-05-25

Family

ID=17526703

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27335290A Pending JPH04151541A (en) 1990-10-15 1990-10-15 Cell analyzing apparatus

Country Status (1)

Country Link
JP (1) JPH04151541A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733835A1 (en) * 1995-05-03 1996-11-08 Hycel Groupe Lisabio Method and system for detecting the lyse point in red blood corpuscles.
FR2735578A1 (en) * 1995-06-13 1996-12-20 Hycel Groupe Lisabio Isolation and discrimination of leukocytes in blood samples
JP2002277381A (en) * 2001-03-21 2002-09-25 Sysmex Corp Particle analyzer
JP2007101314A (en) * 2005-10-03 2007-04-19 Sysmex Corp Device and method for analyzing particles
JP2009002963A (en) * 1997-05-13 2009-01-08 Sysmex Corp Particle measurement apparatus
JP2010156688A (en) * 2008-12-19 2010-07-15 F Hoffmann La Roche Ag Method and device for measuring hemolysis of blood sample
JP2011149832A (en) * 2010-01-22 2011-08-04 Hitachi High-Technologies Corp Autoanalyzer
JP2016186463A (en) * 2015-03-27 2016-10-27 シスメックス株式会社 Blood analyzing device, and blood analyzing method
EP3454038A1 (en) 2017-09-07 2019-03-13 Sysmex Corporation Sample preparing apparatus and sample preparing method
US11226279B2 (en) 2017-05-31 2022-01-18 Sysmex Corporation Sample preparation apparatus, sample preparation system, sample preparation method, and particle analyzer

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726745A (en) * 1995-05-03 1998-03-10 Hycel Groupe Lisabio Process and apparatus for preparing a blood sample for analysis of white blood cells
FR2733835A1 (en) * 1995-05-03 1996-11-08 Hycel Groupe Lisabio Method and system for detecting the lyse point in red blood corpuscles.
FR2735578A1 (en) * 1995-06-13 1996-12-20 Hycel Groupe Lisabio Isolation and discrimination of leukocytes in blood samples
JP2009002963A (en) * 1997-05-13 2009-01-08 Sysmex Corp Particle measurement apparatus
JP2011169916A (en) * 1997-05-13 2011-09-01 Sysmex Corp Apparatus and method for measuring particle
JP2002277381A (en) * 2001-03-21 2002-09-25 Sysmex Corp Particle analyzer
JP4659242B2 (en) * 2001-03-21 2011-03-30 シスメックス株式会社 Particle analyzer
JP2007101314A (en) * 2005-10-03 2007-04-19 Sysmex Corp Device and method for analyzing particles
US8675185B2 (en) 2008-12-19 2014-03-18 Roche Diagnostics Operations, Inc. Determination of haemolysis of a blood sample using gradient analysis
JP2010156688A (en) * 2008-12-19 2010-07-15 F Hoffmann La Roche Ag Method and device for measuring hemolysis of blood sample
JP2011149832A (en) * 2010-01-22 2011-08-04 Hitachi High-Technologies Corp Autoanalyzer
JP2016186463A (en) * 2015-03-27 2016-10-27 シスメックス株式会社 Blood analyzing device, and blood analyzing method
US11226279B2 (en) 2017-05-31 2022-01-18 Sysmex Corporation Sample preparation apparatus, sample preparation system, sample preparation method, and particle analyzer
US11971342B2 (en) 2017-05-31 2024-04-30 Sysmex Corporation Sample preparation apparatus, sample preparation system, sample preparation method, and particle analyzer
EP3454038A1 (en) 2017-09-07 2019-03-13 Sysmex Corporation Sample preparing apparatus and sample preparing method
US10895582B2 (en) 2017-09-07 2021-01-19 Sysmex Corporation Sample preparing apparatus, sample preparing system, sample preparing method, and particle analyzer

Similar Documents

Publication Publication Date Title
EP2972210B1 (en) Dynamic range extension systems and methods for particle analysis in blood samples
EP2312311B1 (en) Determination of white blood cell differential and reticulocytes counts
US7633604B2 (en) Sample analyzer and computer program product
US7618587B2 (en) Analyzers and methods of analyzing blood
WO2016106688A1 (en) Nucleated red blood cell warning method and device, and flow cytometer
US6391263B1 (en) Automated analyzing system and method therefor
JP2004535570A (en) Optical red and white blood cell discrimination
JP2002501188A (en) How to identify nucleated red blood cells
WO2012139047A2 (en) Identifying and enumerating early granulated cells (egcs)
JP2005506525A (en) Methods for measuring nucleated red blood cells
JP2000310642A (en) Automatic analysis system and method therefor
CN112114000A (en) Cell analyzer, method for classifying leukocytes based on impedance method and computer-readable storage medium
US20230296591A1 (en) Sample analysis method, sample analyzer, and computer-readable storage medium
JPH04151541A (en) Cell analyzing apparatus
CN114450589A (en) Method for analyzing red blood cells in blood sample and blood analysis system
Longanbach et al. Automated blood cell analysis
US6670191B2 (en) Method for quantitatively analyzing fragmented red blood cells
JPH07113632B2 (en) White blood cell analysis method
Lee et al. Performance evaluation of Mindray CAL 8000 (BC‐6800 and SC‐120) hematology analyzer and slidemaker/stainer
CN114364983A (en) Method, device and computer readable medium for recognizing hook effect in immunoturbidimetry
Hoffmann et al. Automated counting of cells in cerebrospinal fluid using the CellDyn-4000 haematology analyser
CN113567327A (en) Method, device and system for testing blood
US5045474A (en) Semi-automatic process for white cell differential count
WO2022116112A1 (en) Sample analysis system and method, sample image analysis system and blood analyzer
JPH05322882A (en) Blood analyzing instrument